FDA Approves Subcutaneous Infliximab for IBD
The US Food and Drug Administration (FDA) has approved infliximab-dyyb (Zymfentra, Celltrion USA) for maintenance therapy in adults with moderately to severely active ulcerative colitis […]
Read moreHome » Health News »
The US Food and Drug Administration (FDA) has approved infliximab-dyyb (Zymfentra, Celltrion USA) for maintenance therapy in adults with moderately to severely active ulcerative colitis […]
Read moreA combined team of medical researchers from Columbia University and the University of Michigan has found that, despite multiple mutations, the SARS-CoV-2 omicron subvariant BA.2.86 […]
Read morePriscilla Serrano did everything she could to keep her child’s teeth clean and healthy. She rubbed his gums twice a day with a finger brush […]
Read moreAdditional data from the phase 3 EASE study conducted in patients with epidermolysis bullosa (EB) show that regular application of the topical gel Oleogel-S10 (Filsuvez) […]
Read moreReviewed Understanding why the NHS suffers from endemic levels of bullying and unprofessional behaviors could save the service £2.8 billion a year, according to a […]
Read moreInflammation is a risk factor for many chronic diseases, including cardiovascular disease (CVD), and the impact of diet on inflammation is an area of growing […]
Read moreOver the past decades, Brazil has become the world’s leading soybean producer, as well as the leading consumer of pesticides. Despite concerns about potential public […]
Read moreSource: Read Full Article
Read moreThought LeaderDr. Federico Dajas-BailadorHead of Axon Biology Lab University of Nottingham UK After a recent visit to ELRIGs Drug Discovery 2023, News-Medical sits down with Dr. […]
Read moreIn a recent study published in JAMA Psychiatry, researchers investigate whether reproducible signatures of metabolomic biomarkers could be obtained from dried blood spot samples to […]
Read more